SDS

_____________________________________________________________________
Revision Number: 1
Revision Date: February 11, 2020
7 of 11
Havoline Motor Oil SAE
5W-20, 5W-30, 10W-30
SDS : 48735
Skin Sensitization: The skin sensitization hazard is based on evaluation of data for product components.
Acute Dermal Toxicity: The acute dermal toxicity hazard is based on evaluation of data for product
components.
Acute Oral Toxicity: The acute oral toxicity hazard is based on evaluation of data for product components.
Acute Inhalation Toxicity: The acute inhalation toxicity hazard is based on evaluation of data for product
components.
Acute Toxicity Estimate: Not Determined
Germ Cell Mutagenicity: The hazard evaluation is based on data for components or a similar material.
Carcinogenicity: The hazard evaluation is based on data for components or a similar material.
Reproductive Toxicity: The hazard evaluation is based on data for components or a similar material.
Specific Target Organ Toxicity - Single Exposure: The hazard evaluation is based on data for
components or a similar material.
Specific Target Organ Toxicity - Repeated Exposure: The hazard evaluation is based on data for
components or a similar material.
ADDITIONAL TOXICOLOGY INFORMATION:
During use in engines, contamination of oil with low levels of cancer-causing combustion products
occurs. Used motor oils have been shown to cause skin cancer in mice following repeated application
and continuous exposure. Brief or intermittent skin contact with used motor oil is not expected to have
serious effects in humans if the oil is thoroughly removed by washing with soap and water.
This product contains petroleum base oils which may be refined by various processes including severe
solvent extraction, severe hydrocracking, or severe hydrotreating. None of the oils requires a cancer
warning under the OSHA Hazard Communication Standard (29 CFR 1910.1200). These oils have not
been listed in the National Toxicology Program (NTP) Annual Report nor have they been classified by the
International Agency for Research on Cancer (IARC) as; carcinogenic to humans (Group 1), probably
carcinogenic to humans (Group 2A), or possibly carcinogenic to humans (Group 2B).